ArticleOphthalmic epidemiology2016
Population-Based Trachoma Mapping in Six Evaluation Units of Papua New Guinea.
Article in Ophthalmic epidemiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.
- A search for trachoma in Timor-Leste: no evidence to justify undertaking population-based prevalence surveys.Ophthalmic epidemiology · 2018Pooled it
- A systematic review of historical and contemporary evidence of trachoma endemicity in the Pacific Islands.PloS one · 2018Pooled it
- Corneal pannus, Herbert's pits and conjunctival inflammation in older children in Papua New Guinea.Ophthalmic epidemiology · 2024Article
- Genetic Signatures of Positive Selection in Human Populations Adapted to High Altitude in Papua New Guinea.Genome biology and evolution · 2024Article
- Baseline Prevalence of Trachoma in 13 Local Government Areas of Borno State, Nigeria.Ophthalmic epidemiology · 2023Article
- A national survey integrating clinical, laboratory, and WASH data to determine the typology of trachoma in Nauru.PLoS neglected tropical diseases · 2022Article
- Conjunctival Scarring, Corneal Pannus, and Herbert's Pits in Adolescent Children in Trachoma-endemic Populations of the Solomon Islands and Vanuatu.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021Article
- Ocular Chlamydia trachomatis infection, anti-Pgp3 antibodies and conjunctival scarring in Vanuatu and Tarawa, Kiribati before antibiotic treatment for trachoma.The Journal of infection · 2020Article
- Association of environmental risk factors and trachoma in Gashoho Health District, Burundi.African health sciences · 2020Article
- The global burden of trichiasis in 2016.PLoS neglected tropical diseases · 2019Article
- A Population-Based Trachoma Prevalence Survey Covering Seven Districts of Sangha and Likouala Departments, Republic of the Congo.Ophthalmic epidemiology · 2018Article
- Trachoma in Viet Nam: results of 11 surveillance surveys conducted with the Global Trachoma Mapping Project.Ophthalmic epidemiology · 2018Article
- Prevalence of trachoma in Yemen: results of population-based prevalence surveys of 42 evaluation units in nine governorates.Ophthalmic epidemiology · 2018Article
- Prevalence of Trachoma in Senegal: Results of Baseline Surveys in 17 Districts.Ophthalmic epidemiology · 2018Article
- Impact Survey Results after SAFE Strategy Implementation in 15 Local Government Areas of Kebbi, Sokoto and Zamfara States, Nigeria.Ophthalmic epidemiology · 2018Article
- The Epidemiology of Trachoma in Mozambique: Results of 96 Population-Based Prevalence Surveys.Ophthalmic epidemiology · 2018Article
- Quality Assurance and Quality Control in the Global Trachoma Mapping Project.The American journal of tropical medicine and hygiene · 2018Article
- The cost of mapping trachoma: Data from the Global Trachoma Mapping Project.PLoS neglected tropical diseases · 2017Article
- Mapping Trachoma in the Solomon Islands: Results of Three Baseline Population-Based Prevalence Surveys Conducted with the Global Trachoma Mapping Project.Ophthalmic epidemiology · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 6 institutions in 4 countries.
Funding
Abstract
purposeWe sought to determine the prevalence of trachomatous inflammation - follicular (TF) in children aged 1-9 years, and trachomatous trichiasis (TT) in those aged ≥15 years, in suspected trachoma-endemic areas of Papua New Guinea (PNG).
methodsWe carried out six population-based prevalence surveys using the protocol developed as part of the Global Trachoma Mapping Project.
resultsA total of 19,013 individuals were sampled for inclusion, with 15,641 (82.3%) consenting to participate. Four evaluation units had prevalences of TF in children ≥10%, above which threshold the World Health Organization (WHO) recommends mass drug administration (MDA) of azithromycin for at least three years; Western Province (South Fly/Daru) 11.2% (95% confidence interval, CI, 6.9-17.0%), Southern Highlands (East) 12.2% (95% CI 9.6-15.0%), Southern Highlands (West) 11.7% (95% CI 8.5-15.3%), and West New Britain 11.4% (95% CI 8.7-13.9%). TF prevalence was 5.0-9.9% in Madang (9.4%, 95% CI 6.1-13.0%) and National Capital District (6.0%. 95% CI 3.2-9.1%) where consideration of a single round of MDA is warranted. Cases of TT were not found outside West New Britain, in which four cases were seen, generating an estimated population-level prevalence of TT in adults of 0.10% (95% CI 0.00-0.40%) for West New Britain, below the WHO elimination threshold of 0.2% of those aged ≥15 years.
conclusionTrachoma is a public health issue in PNG. However, other than in West New Britain, there are few data to support the idea that trachoma is a cause of blindness in PNG. Further research is needed to understand the stimulus for the active trachoma phenotype in these populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.